Study design: features of non-experimental studies

Vittoria Colamesta, Riccardo Pistelli

Source: Eur Respir Monogr 2014; 65: 249-256

Journal Issue: Respiratory Epidemiology

Disease area: Airway diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Vittoria Colamesta, Riccardo Pistelli. Study design: features of non-experimental studies. Eur Respir Monogr 2014; 65: 249-256

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

The AMBITION study: design and results Source: International Congress 2014 – Combination therapy in pulmonary arterial hypertension (PAH): the evidence grows Year: 2014
Overview on observational studies Source: ERS Course 2015 Year: 2015
The ESCAPE study: design and exposure assessment results Source: Annual Congress 2013 –Highlights from ESCAPE Year: 2013
The study design Source: ERS Course 2015 Year: 2015
Key ongoing issues in trial design Source: Eur Respir Monogr 2016; 71: 253-259 Year: 2016
Validation of soluble mesothelin: design and preliminary results of a Belgian multicentric observational study Source: Annual Congress 2009 - Diagnosis and management of pleural effusions and mesothelioma: improving old techniques and new tools Year: 2009
Basic concepts and design of COPACETIC Source: Annual Congress 2009 - EU Research Programmes: 1.GABRIEL 2.EvA 3.COPACETIC Year: 2009
COVID-19 pneumothorax in the UK: a prospective observational study using the ISARIC WHO clinical characterisation protocol Source: Eur Respir J, 58 (3) 2100929; 10.1183/13993003.00929-2021 Year: 2021
The EvA study: Characteristics of the study population Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012
Observational studies assessing the pharmacological treatment of obstructive lung disease: strengths, challenges and considerations for study design Source: ERJ Open Res, 6 (4) 00044-2020; 10.1183/23120541.00044-2020 Year: 2020
Negative clinical trials in sarcoidosis: failed therapies or flawed study design? Source: Eur Respir J 2014; 44: 1123-1126 Year: 2014
Clinical Assessment of Glycopyrronium in COPD phenotypes and ACOS: Prospective, case control, observational study Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019
Systematic evaluation and external validation of 22 prognostic models among hospitalised adults with COVID-19: an observational cohort study Source: Eur Respir J, 56 (6) 2003498; 10.1183/13993003.03498-2020 Year: 2020
Lung microbiome: study design and standardisation Source: International Congress 2018 – ME2 Lung microbiome: study design and standardisation FULLY BOOKED Year: 2018